FREE screenings for Nonalcoholic Fatty Liver Disease in San Antonio, TX
Clay Dehn, vice president of clinical pharmacology services at Endeavor Clinical Trials, explains how Nonalcoholic Fatty Liver Disease (NAFLD) is prevalent in the Hispanic community and provides insight on how to get a free screening.
Unite Against COVID-19
COVID-19 Vaccine Study
If you qualify you may:
- See a physician or medical staff at no cost
- Receive compensation for time and travel
Welcome to Evolution Research Group!
Together we are one of the largest research organizations in the nation focusing on the conduct of clinical trials for healthy individuals and those suffering from psychiatric disorders, pain, Alzheimer’s, hepatic, renal and other debilitating diseases. Our research subjects make medical discoveries and scientific developments possible and we are here to support you.
Choosing to participate in a clinical research trial is a personal decision. Our research specialists are here to answer your questions and to help you along the way. Contact us today to see how you can be a part of identifying breakthrough treatments.
Studies We Conduct at Evolution Research Group
- Alzheimer’s Disease
- Binge Eating
- Bipolar Disorder
- Chronic Back Pain
- Chronic Migraine
- Essential Tremor
- Human Abuse Liability
- Healthy Volunteers
- Hepatic Impairment
- Major Depressive Disorder
- Memory Loss
- Opioid Addiction
- Renal Impairment
- Senior Healthy Volunteers
- Smoking Cessation
- Tardive Dyskinesia
Clinical Research Education & Blog
June kicks off Men’s Health Awareness Month. It is an annual focus for men of all ages to strive for better health by joining any of the various activities peppering the month. Learning more about the common conditions male populations face and their symptoms is vital to early detection and treatment success. Low T is
In the time it takes to complete a few of these sentences, someone will receive an Alzheimer’s diagnosis. Over 50 million people around the world are living with a form of dementia. That number is expected to soar to over 82 million before this decade ends. Prioritizing awareness is no longer an option. Across the world this
Non-alcoholic steatohepatitis (NASH) is a form of fatty liver disease where extra fat builds up in the liver and causes it to swell and become damaged. It is a modern-day epidemic of surging waistlines and unhealthy lifestyles. NASH takes years to develop and has little to no symptoms. It can cause irreversible damage leading to